Pregnancy after breast cancer

Kathryn J Ruddy, Ann H. Partridge

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Approximately one in every 210 women will be diagnosed with breast cancer before the age of 40. Consequently, in the United States alone, more than 250,000 women under 40 have a history of breast cancer, and more than 10,000 additional young women are diagnosed annually. Many of these young survivors, and some older women, are interested in having a biologic child after breast cancer. Because nulliparity and late first pregnancy increase risk for breast cancer, a disproportionate number of young breast cancer patients may desire a future pregnancy at diagnosis compared to survivors of other adult malignancies. While breast cancer treatments including chemotherapy and hormonal therapy may result in ovarian dysfunction and associated infertility, many young breast cancer survivors remain premenopausal after therapy is complete. Studies suggest that 5-15% of young women with breast cancer will later become pregnant. However, patients, loved ones, and physicians may struggle with the idea of childbearing in the setting of potential disease recurrence as well as the theoretical concern that subsequent pregnancy may increase this risk. Hypothetically, residual breast cancer cells, if present, could be stimulated by reproductive hormones, particularly in women with a history of a hormone receptor-positive breast cancer, in whom antiestrogen therapy improves survival. Given these concerns, familiarity with current information regarding pregnancy after breast cancer, and the limitations of the available data, may help physicians to counsel young breast cancer survivors about their cancer and their reproductive health issues.

Original languageEnglish (US)
Title of host publicationBreast Surgical Techniques and Interdisciplinary Management
PublisherSpringer New York
Pages945-951
Number of pages7
ISBN (Print)9781441960757
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Breast Neoplasms
Pregnancy
Survivors
Hormones
Physicians
Estrogen Receptor Modulators
Reproductive Health
Residual Neoplasm
Therapeutics
Parity
Infertility
Neoplasms
Recurrence
Drug Therapy
Survival

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ruddy, K. J., & Partridge, A. H. (2011). Pregnancy after breast cancer. In Breast Surgical Techniques and Interdisciplinary Management (pp. 945-951). Springer New York. https://doi.org/10.1007/978-1-4419-6076-4_78

Pregnancy after breast cancer. / Ruddy, Kathryn J; Partridge, Ann H.

Breast Surgical Techniques and Interdisciplinary Management. Springer New York, 2011. p. 945-951.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ruddy, KJ & Partridge, AH 2011, Pregnancy after breast cancer. in Breast Surgical Techniques and Interdisciplinary Management. Springer New York, pp. 945-951. https://doi.org/10.1007/978-1-4419-6076-4_78
Ruddy KJ, Partridge AH. Pregnancy after breast cancer. In Breast Surgical Techniques and Interdisciplinary Management. Springer New York. 2011. p. 945-951 https://doi.org/10.1007/978-1-4419-6076-4_78
Ruddy, Kathryn J ; Partridge, Ann H. / Pregnancy after breast cancer. Breast Surgical Techniques and Interdisciplinary Management. Springer New York, 2011. pp. 945-951
@inbook{74d2237a9c1b4297a5bbdaae96b37c47,
title = "Pregnancy after breast cancer",
abstract = "Approximately one in every 210 women will be diagnosed with breast cancer before the age of 40. Consequently, in the United States alone, more than 250,000 women under 40 have a history of breast cancer, and more than 10,000 additional young women are diagnosed annually. Many of these young survivors, and some older women, are interested in having a biologic child after breast cancer. Because nulliparity and late first pregnancy increase risk for breast cancer, a disproportionate number of young breast cancer patients may desire a future pregnancy at diagnosis compared to survivors of other adult malignancies. While breast cancer treatments including chemotherapy and hormonal therapy may result in ovarian dysfunction and associated infertility, many young breast cancer survivors remain premenopausal after therapy is complete. Studies suggest that 5-15{\%} of young women with breast cancer will later become pregnant. However, patients, loved ones, and physicians may struggle with the idea of childbearing in the setting of potential disease recurrence as well as the theoretical concern that subsequent pregnancy may increase this risk. Hypothetically, residual breast cancer cells, if present, could be stimulated by reproductive hormones, particularly in women with a history of a hormone receptor-positive breast cancer, in whom antiestrogen therapy improves survival. Given these concerns, familiarity with current information regarding pregnancy after breast cancer, and the limitations of the available data, may help physicians to counsel young breast cancer survivors about their cancer and their reproductive health issues.",
author = "Ruddy, {Kathryn J} and Partridge, {Ann H.}",
year = "2011",
doi = "10.1007/978-1-4419-6076-4_78",
language = "English (US)",
isbn = "9781441960757",
pages = "945--951",
booktitle = "Breast Surgical Techniques and Interdisciplinary Management",
publisher = "Springer New York",

}

TY - CHAP

T1 - Pregnancy after breast cancer

AU - Ruddy, Kathryn J

AU - Partridge, Ann H.

PY - 2011

Y1 - 2011

N2 - Approximately one in every 210 women will be diagnosed with breast cancer before the age of 40. Consequently, in the United States alone, more than 250,000 women under 40 have a history of breast cancer, and more than 10,000 additional young women are diagnosed annually. Many of these young survivors, and some older women, are interested in having a biologic child after breast cancer. Because nulliparity and late first pregnancy increase risk for breast cancer, a disproportionate number of young breast cancer patients may desire a future pregnancy at diagnosis compared to survivors of other adult malignancies. While breast cancer treatments including chemotherapy and hormonal therapy may result in ovarian dysfunction and associated infertility, many young breast cancer survivors remain premenopausal after therapy is complete. Studies suggest that 5-15% of young women with breast cancer will later become pregnant. However, patients, loved ones, and physicians may struggle with the idea of childbearing in the setting of potential disease recurrence as well as the theoretical concern that subsequent pregnancy may increase this risk. Hypothetically, residual breast cancer cells, if present, could be stimulated by reproductive hormones, particularly in women with a history of a hormone receptor-positive breast cancer, in whom antiestrogen therapy improves survival. Given these concerns, familiarity with current information regarding pregnancy after breast cancer, and the limitations of the available data, may help physicians to counsel young breast cancer survivors about their cancer and their reproductive health issues.

AB - Approximately one in every 210 women will be diagnosed with breast cancer before the age of 40. Consequently, in the United States alone, more than 250,000 women under 40 have a history of breast cancer, and more than 10,000 additional young women are diagnosed annually. Many of these young survivors, and some older women, are interested in having a biologic child after breast cancer. Because nulliparity and late first pregnancy increase risk for breast cancer, a disproportionate number of young breast cancer patients may desire a future pregnancy at diagnosis compared to survivors of other adult malignancies. While breast cancer treatments including chemotherapy and hormonal therapy may result in ovarian dysfunction and associated infertility, many young breast cancer survivors remain premenopausal after therapy is complete. Studies suggest that 5-15% of young women with breast cancer will later become pregnant. However, patients, loved ones, and physicians may struggle with the idea of childbearing in the setting of potential disease recurrence as well as the theoretical concern that subsequent pregnancy may increase this risk. Hypothetically, residual breast cancer cells, if present, could be stimulated by reproductive hormones, particularly in women with a history of a hormone receptor-positive breast cancer, in whom antiestrogen therapy improves survival. Given these concerns, familiarity with current information regarding pregnancy after breast cancer, and the limitations of the available data, may help physicians to counsel young breast cancer survivors about their cancer and their reproductive health issues.

UR - http://www.scopus.com/inward/record.url?scp=84887941889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887941889&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-6076-4_78

DO - 10.1007/978-1-4419-6076-4_78

M3 - Chapter

AN - SCOPUS:84887941889

SN - 9781441960757

SP - 945

EP - 951

BT - Breast Surgical Techniques and Interdisciplinary Management

PB - Springer New York

ER -